Human Pathology
Volume 41, Issue 9 , Pages 1255-1264 , September 2010

Involvement of inactive GSK3β overexpression in tumorigenesis and progression of gastric carcinomas

  • Hua-chuan Zheng, MD, PhD

      Affiliations

    • Department of Biochemistry and Molecular Biology, College of Basic Medicine, China Medical University, Shenyang 110001, China
    • Corresponding Author InformationCorresponding author.
    • ,
  • Xiao-yan Xu, PhD

      Affiliations

    • Department of Biochemistry and Molecular Biology, College of Basic Medicine, China Medical University, Shenyang 110001, China
    • ,
  • Pu Xia, MD

      Affiliations

    • Department of Biochemistry and Molecular Biology, College of Basic Medicine, China Medical University, Shenyang 110001, China
    • ,
  • Miao Yu, MD

      Affiliations

    • Department of Surgical Oncology, The First Affiliated Hospital of China Medical University, Shenyang 110001, China
    • ,
  • Hiroyuki Takahashi, MD, PhD

      Affiliations

    • Kanagawa Cancer Center, Yohohama 241-0815, Japan
    • ,
  • Yasuo Takano, MD, PhD

      Affiliations

    • Kanagawa Cancer Center, Yohohama 241-0815, Japan

Received 27 November 2009 ,Revised 30 January 2010 ,Accepted 5 February 2010.

References 

  1. Droucheau E, Primot A, Thomas V, Mattei D, Knockaert M, Richardson C, et al. Plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors. Biochim Biophys Acta. 2004;1697:181–196
  2. Ali A, Hoeflich KP, Woodgett JR. Glycogen synthase kinase-3: properties, functions, and regulation. Chem Rev. 2001;101:2527–2540
  3. Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J. 2001;359:1–16
  4. Shakoori A, Ougolkov A, Yu ZW, Zhang B, Modarressi MH, Billadeau DD, et al. Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation. Biochem Biophys Res Commun. 2005;334:1365–1373
  5. Patel S, Doble B, Woodgett JR. Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword?. Biochem Soc Trans. 2004;32:803–808
  6. Kim L, Kimmel AR. GSK3, a master switch regulating cell-fate specification and tumorigenesis. Curr Opin Genet Dev. 2000;10:508–514
  7. Pearl LH, Barford D. Regulation of protein kinases in insulin, growth factor and Wnt signalling. Curr Opin Struct Biol. 2002;12:761–767
  8. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature. 2000;406:86–90
  9. Schwabe RF, Brenner DA. Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes. Am J Physiol Gastrointest Liver Physiol. 2002;283:G204–211
  10. Takahashi-Yanaga F, Sasaguri T. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs. J Pharmacol Sci. 2009;109:179–183
  11. Blankesteijn WM, van de Schans VA, ter Horst P, Smits JF. The Wnt/frizzled/GSK-3 beta pathway: a novel therapeutic target for cardiac hypertrophy. Trends Pharmacol Sci. 2008;29:175–180
  12. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol. 2003;56:1–9
  13. Zheng H, Saito H, Masuda S, Yang X, Takano Y. Phosphorylated GSK3beta-ser9 and EGFR are good prognostic factors for lung carcinomas. Anticancer Res. 2007;27:3561–3569
  14. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Miwa S, et al. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol. 2007;60:273–277
  15. Sobin LH, Wittekind CH. TNM Classification of Malignant Tumors. 6th ed. Hoboken (NJ): John Wiley and Sons; 2002;
  16. Zheng HC, Li XH, Hara T, Masuda S, Yang XH, Guan YF, et al. Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas. Virchows Arch. 2008;452:525–534
  17. Kumada T, Tsuneyama K, Hatta H, Ishizawa S, Takano Y. Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol. 2004;17:1141–1149
  18. Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa S, et al. EMMPRIN expression contributes to growth and angiogenesis of gastric carcinoma: a good marker to indicate local invasion and prognosis. Br J cancer. 2006;95:1371–1378
  19. Ban KC, Singh H, Krishnan R, Seow HF. GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma. Cancer Lett. 2003;199:201–208
  20. Desbois-Mouthon C, Blivet-Van Eggelpoel MJ, Beurel E, Boissan M, et al. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells. Hepatology. 2002;36:1528–1536
  21. Mulholland DJ, Dedhar S, Wu H, Nelson CC. PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer. Oncogene. 2006;25:329–337
  22. Thiel A, Heinonen M, Rintahaka J, Hallikainen T, Hemmes A, Dixon DA, et al. Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3beta in gastric cancer cells. J Biol Chem. 2006;281:4564–4569
  23. Oshima H, Oshima M, Inaba K, Taketo MM. Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J. 2004;23:1669–1678
  24. Chen CN, Hsieh FJ, Cheng YM, Chang KJ, Lee PH. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer. J Surg Oncol. 2006;94:226–233
  25. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, et al. Expressions of MMP-2, MMP-9, and VEGF were closely linked to growth, invasion, metastasis, angiogenesis of gastric carcinoma. Anticancer Res. 2006;26:3579–3583
  26. Skurk C, Maatz H, Rocnik E, Bialik A, Force T, Walsh K. Glycogen-Synthase Kinase3beta /beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells. Circ Res. 2005;96:308–318

☆ This study was supported by Shenyang Outstanding Talent Foundation of China, Liaoning BaiQianWan Talents Program, Scientific and Technological Projects for Oversea Returned persons, Ministry of Personnel; Shenyang Science and Technology Grand(1091175-1-00); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; Grant-in aid for Scientific Research from the Ministry of Education, Culture, Sports and Technology of Japan (20659109; 21790624), Japanese Smoking Research Foundation and Japanese Uehara Memorial Foundation.

PII: S0046-8177(10)00067-5

doi: 10.1016/j.humpath.2010.02.003

Human Pathology
Volume 41, Issue 9 , Pages 1255-1264 , September 2010

Article Tools

* Image Usage & Resolution